# Timepoint-Specific Benchmarking of Deep Learning Models for Glioblastoma Follow-Up MRI

arXiv: https://arxiv.org/abs/2511.18595 · HTML: https://mlsanity.com/paper/2511.18595/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Placed in Mamba for medical image analysis, one of 10 directions in State-space sequence models (S4, Mamba).
- Builds on 2 of its 39 references that are in the map.
- First posted on arXiv 23 Nov 2025.

## Placed in

- State-space sequence models (S4, Mamba) / [Mamba for medical image analysis](https://mlsanity.com/ssm/mamba-for-medical-image-analysis/)

## Builds on (most cited first, 2 of 2)

- [DC-AL GAN: Pseudoprogression and True Tumor Progression of Glioblastoma Multiform Image Classification Based on DCGAN and AlexNet](https://mlsanity.com/paper/1902.06085/) (2019)
- [A Self-supervised Multimodal Deep Learning Approach to Differentiate Post-radiotherapy Progression from Pseudoprogression in Glioblastoma](https://mlsanity.com/paper/2502.03999/) (2025)

## Abstract (arXiv)

Differentiating true tumor progression (TP) from treatment-related pseudoprogression (PsP) in glioblastoma remains challenging, especially at early follow-up. We present the first stage-specific, cross-sectional benchmarking of deep learning models for follow-up MRI using the Burdenko GBM Progression cohort (n = 180). We analyze different post-RT scans independently to test whether architecture performance depends on time-point. Eleven representative DL families (CNNs, LSTMs, hybrids, transformers, and selective state-space models) were trained under a unified, QC-driven pipeline with patient-level cross-validation. Across both stages, accuracies were comparable (~0.70-0.74), but discrimination improved at the second follow-up, with F1 and AUC increasing for several models, indicating richer separability later in the care pathway. A Mamba+CNN hybrid consistently offered the best accuracy-efficiency trade-off, while transformer variants delivered competitive AUCs at substantially higher computational cost and lightweight CNNs were efficient but less reliable. Performance also showed sensitivity to batch size, underscoring the need for standardized training protocols. Notably, absolute discrimination remained modest overall, reflecting the intrinsic difficulty of TP vs. PsP and the dataset's size imbalance. These results establish a stage-aware benchmark and motivate future work incorporating longitudinal modeling, multi-sequence MRI, and larger multi-center cohorts.